Q1 2026 · 13F-HR
AJU IB Investment Co., Ltd.holdings as filed
Filed 2026-05-08 · accession 0001140361-26-019665
$30.5M
Reported value
6
Positions
2026-03-31
Period end
The Brief · AJU IB Investment Co., Ltd. · Q1 2026
AI · grounded in 13F
AJU IB Investment Co., Ltd. closed its position in RLYB with a reduction of $4.14M. The fund also exited positions in RAPT and XLO, reducing those holdings by $421,241 and $427,488 respectively. To offset these exits, the fund opened new positions in RLYB for $846,176 and XLO for $401,115.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $25.7M | 84.1% | 223,486 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $1.6M | 5.36% | 19,648 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $1.5M | 5.05% | 816,375 | Common | SOLE |
| 75120L209 | RLYB | RALLYBIO CORP | $846,176 | 2.77% | 94,334 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $435,925 | 1.43% | 17,500 | Common | SOLE |
| 98422T209 | XLO | XILIO THERAPEUTICS INC | $401,115 | 1.31% | 47,695 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.